Korean J Obstet Gynecol.  2008 Jan;51(1):100-103.

A case of telangiectasis of the uterus: uncontrolled massive uterine bleeding after gnrh agonist therapy

Affiliations
  • 1Department of Obstetrics and Gynecology, Cheil General Hospital and Women's Healthcare Center, Kwandong University College of Medicine, Seoul, Korea. pil0325@hotmail.com
  • 2Department of Pathology, Cheil General Hospital and Women's Healthcare Center, Kwandong University College of Medicine, Seoul, Korea.

Abstract

Telangiectasis of the uterus is an extremely rare but life-threatening disease because of massive uterine bleeding. The usage of GnRH agonist can cause regression and atrophy of the endometrium through induction of hypoestrogenism by pituitary down-regulation. But there is no clear explanation or report in the literature showing the relationship between uterine telangiectasis and GnRH agonist usage. We have experienced a patient with uncontrolled massive uterine bleeding after GnRH agonist treatment, who needed emergency hysterectomy. Pathologic tissue examination showed telangiectasis of the endometrium and myometrium. This is the first case report of telagiectasis of the uterus without other organ involvement. We report this case with a brief review of the literatures.

Keyword

Telangiectasis; Uterus; Uterine bleeding; GnRH agonist

MeSH Terms

Animals
Atrophy
Down-Regulation
Emergencies
Endometrium
Female
Gonadotropin-Releasing Hormone
Humans
Hysterectomy
Mice
Myometrium
Telangiectasis
Uterine Hemorrhage
Uterus
Gonadotropin-Releasing Hormone
Full Text Links
  • KJOG
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr